Literature DB >> 6519114

Avascular necrosis of bone in neuroblastoma treated with combination chemotherapy.

E Ishii, N Yoshida, S Miyazaki.   

Abstract

We treated two children with neuroblastoma and during the course of chemotherapy, avascular necrosis of the femoral head occurred. The main pathogenetic factor of this necrosis may be the toxic effect of cyclophosphamide.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6519114     DOI： 10.1007/bf00445806

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  10 in total

1.  Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits.

Authors:  G J Wang; D E Sweet; S I Reger; R C Thompson
Journal:  J Bone Joint Surg Am       Date:  1977-09       Impact factor: 5.284

2.  Histologic demonstration of fat emboli in aseptic necrosis associated with hypercortisonism.

Authors:  D E Fisher; W H Bickel; K E Holley
Journal:  Mayo Clin Proc       Date:  1969-04       Impact factor: 7.616

3.  Aseptic osteonecrosis in children treated for acute lymphoblastic leukemia and aplastic anemia.

Authors:  G Prindull; W Weigel; E Jentsch; A Enderle; H G Willert
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

4.  Osteonecrosis after chemotherapy.

Authors:  R Obrist; D Hartmann; J P Obrecht
Journal:  Lancet       Date:  1978-06-17       Impact factor: 79.321

5.  Osteonecrosis of the femoral head in patients with lymphoma treated with intermittent combination chemotherapy (including corticosteroids).

Authors:  D C Ihde; V T DeVita
Journal:  Cancer       Date:  1975-11       Impact factor: 6.860

6.  Osteonecrosis in patients with malignant lymphoma: a review of twenty-five cases.

Authors:  I A Engel; D J Straus; M Lacher; J Lane; J Smith
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

7.  Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy.

Authors:  L R Prosnitz; J P Lawson; G E Friedlaender; L R Farber; J F Pezzimenti
Journal:  Cancer       Date:  1981-06-15       Impact factor: 6.860

8.  Avascular necrosis of bone caused by combination chemotherapy without corticosteroids.

Authors:  P G Harper; C Trask; R L Souhami
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

9.  Avascular necrosis of bone complicating treatment of malignant lymphoma.

Authors:  J C Thorne; W K Evans; R E Alison; V Fournasier
Journal:  Am J Med       Date:  1981-11       Impact factor: 4.965

10.  Cortisone induced bone changes and its response to lipid clearing agents.

Authors:  G J Wang; D B Moga; W G Richemer; D E Sweet; S I Reger; R C Thompson
Journal:  Clin Orthop Relat Res       Date:  1978 Jan-Feb       Impact factor: 4.176
  10 in total
  5 in total

Review 1.  Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.

Authors:  Smita Bhatia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10       Impact factor: 4.254

Review 2.  Minimising the long-term adverse effects of childhood leukaemia therapy.

Authors:  Claudia Langebrake; Dirk Reinhardt; Jörg Ritter
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.

Authors:  J Calvo-Alén; G McGwin; S Toloza; M Fernández; J M Roseman; H M Bastian; E J Cepeda; E B González; B A Baethge; B J Fessler; L M Vilá; J D Reveille; G S Alarcón
Journal:  Ann Rheum Dis       Date:  2005-11-03       Impact factor: 19.103

4.  Aseptic osteonecroses in the treatment of childhood acute leukaemias.

Authors:  T Bömelburg; H J von Lengerke; J Ritter
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

5.  Osteonecrosis in patients with acute lymphoblastic leukaemia: a national questionnaire study.

Authors:  Nadia Laila Amin; Richard Feltbower; Sally Kinsey; Ajay Vora; Beki James
Journal:  BMJ Paediatr Open       Date:  2017-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.